Two years after the Swiss facility discovery, Elena received news that made everything real in a way theoretical threat had never managed. A research team in Brazil reported suspected pathogenic material in an isolated community.
"Confirmed match to the engineered strain," Dr. Chen reported during the emergency briefing, her voice carrying controlled urgency. "Genetic signature matches Klaus Webb's cultivated samples exactly. We're not looking at theoretical risk anymore."
Elena felt the room shift. This was what they'd prepared for. This was why they'd spent two years developing vaccine, manufacturing capability, distribution networks. This was the moment that determined whether all that work actually meant something.
"Location specifics?" she asked.
"Remote village in the sss region,
